Bitte einloggen
Sie müssen angemeldet sein, um die Kontaktanfrage zu senden.
Standverwaltung
Option auswählen
Delta Med S.p.A.
Via Guido Rossa, 20,
46019
Viadana (MN)
Italien
Italien
Kontaktdaten an Aussteller übermitteln
Übermitteln Sie dem Aussteller Ihre Kontaktdaten. Optional können Sie eine persönliche Nachricht ergänzen.
Gegenstand der Übermittlung personenbezogener Daten sind Ihr Name, Ihre Telefonnummer und Ihre E-Mail Adresse. Die Messe Düsseldorf GmbH weist ausdrücklich darauf hin, dass für die Übermittlung personenbezogener Daten in Drittländer, für die kein Angemessenheitsbeschluss der EU-Kommission vorliegt, der ein angemessenes Datenschutzniveau attestiert, nicht sichergestellt ist, dass geeignete Garantien für den Schutz personenbezogener bestehen.
Ein Fehler ist aufgetreten
Bitte überprüfen Sie Ihre Internetverbindung oder versuchen Sie es zu einem späteren Zeitpunkt noch einmal.
Nachricht erfolgreich gesendet
Ihre Nachricht an den Aussteller wurde erfolgreich gesendet.
Ansprechpartner
Andrea Lacqua
Sales Manager IVC & NFC
E-Mail
a.lacqua@deltamed.biz
Andrea Delù
Sales Manager - Critical Care
E-Mail
a.delu@deltamed.biz
Elena Malagutti
Sales Manager Closed System IV catheter
E-Mail
sales1@tipromed.it
Gabriele Giovanelli
CEO
E-Mail
g.giovanelli@deltamed.biz
Unser Angebot
Produktkategorien
- 02 Endproduktefertigung
- 02.02 Katheter
Katheter
Unsere Produkte
3. CLOSED SYSTEM safety IV catheters
https://deltamed.pro/en/products/iv-catheters/closed-system
5. Microcath- Long Cannulas
https://deltamed.pro/en/products/critical-care/long-cannulae
11. Securement devices
https://deltamed.pro/en/products/vascular-accessories/alfalock-range
Über uns
Firmenporträt
Company Description
⚫ Founded in 1993 and located near Mantua (Italy), Delta Med is a leading high-quality producer of medical devices, specializing in the segment of vascular access devices
⚫ In December 2015 Delta Med was acquired by Augens Capital, an Italian private equity investor, in partnership with Deutsche Bank Wealth & Asset Management, from listed group Eukedos
⚫ Following the acquisition, the company has pursued a growth strategy aiming to build a full portfolio of vascular access devices including value-added peripheral and specialty central venous catheters
⚫ During Augens’ tenure, Delta Med has completed the acquisition of three companies, Tipromed and Alfamed in 2017, and Bioengineering Laboratories (BEL) in 2018 all operating in high value-added niches of the Intravenous Catheters (IVCs), urodynamics and hemodialysis markets
⚫ Thanks to these acquisitions, Delta Med is now one of the few sector players able to supply the whole range of IVC products
⚫ The company directly sells to hospital and public health companies in the PIVC Italian market. Export sales are carried out through several relationships with
global OEM customers and important distribution agreements with sector
giants such as Smiths Medical, Terumo, Fresenius, Becton Dickinson and Laborie
⚫ Revenues are expected to increase substantially in the next few years, thanks to sales arising from recently launched products, new OEM and distribution contracts and to the realization of commercial synergies to supply Tipromed’s, Alfamed’s and BEL’s products in the international markets
⚫ The company is expected to generate €25mn of sales in 2020, with €5mn EBITDA. These figures do not include any business acceleration due to Covid- 19 (+76% YTD order backlog increase vs. last year)
⚫ Founded in 1993 and located near Mantua (Italy), Delta Med is a leading high-quality producer of medical devices, specializing in the segment of vascular access devices
⚫ In December 2015 Delta Med was acquired by Augens Capital, an Italian private equity investor, in partnership with Deutsche Bank Wealth & Asset Management, from listed group Eukedos
⚫ Following the acquisition, the company has pursued a growth strategy aiming to build a full portfolio of vascular access devices including value-added peripheral and specialty central venous catheters
⚫ During Augens’ tenure, Delta Med has completed the acquisition of three companies, Tipromed and Alfamed in 2017, and Bioengineering Laboratories (BEL) in 2018 all operating in high value-added niches of the Intravenous Catheters (IVCs), urodynamics and hemodialysis markets
⚫ Thanks to these acquisitions, Delta Med is now one of the few sector players able to supply the whole range of IVC products
⚫ The company directly sells to hospital and public health companies in the PIVC Italian market. Export sales are carried out through several relationships with
global OEM customers and important distribution agreements with sector
giants such as Smiths Medical, Terumo, Fresenius, Becton Dickinson and Laborie
⚫ Revenues are expected to increase substantially in the next few years, thanks to sales arising from recently launched products, new OEM and distribution contracts and to the realization of commercial synergies to supply Tipromed’s, Alfamed’s and BEL’s products in the international markets
⚫ The company is expected to generate €25mn of sales in 2020, with €5mn EBITDA. These figures do not include any business acceleration due to Covid- 19 (+76% YTD order backlog increase vs. last year)